Ligand Pharmaceuticals (LGND) Equity Income (2015 - 2020)
Ligand Pharmaceuticals (LGND) reported Equity Income of -$25.46 million for Q1 2020, compared with $17.29 million a year earlier.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Equity Income (2015 - 2020) Analysis & Trends
Over the twelve months ended Mar 31, 2020, Ligand Pharmaceuticals' Equity Income came in at -$39.86 million; for FY2019, it came in at $2.89 million, down 93.9% from FY2018.
- By year, Equity Income came in at $47.66 million in FY2018, $1.11 million in FY2017, -$23.13 million in FY2016 and -$5.14 million in FY2015.
- The Q1 2020 figure ranks as the lowest quarterly Equity Income since Q4 2018.
- Per Business Quant data, the three quarters before Q1 2020 came in at $8.48 million (Q4 2019), -$10.52 million (Q3 2019) and -$12.37 million (Q2 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -10.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Ligand Pharmaceuticals | 6.22 Bn | 2.69 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | -25.46 Mn |
| Dec 31, 2019 | 8.48 Mn |
| Sep 30, 2019 | -10.52 Mn |
| Jun 30, 2019 | -12.37 Mn |
| Mar 31, 2019 | 17.29 Mn |
| Dec 31, 2018 | -74.02 Mn |
| Sep 30, 2018 | 59.87 Mn |
| Jun 30, 2018 | 39.88 Mn |
| Mar 31, 2018 | 21.93 Mn |
| Dec 31, 2017 | 4.46 Mn |
| Sep 30, 2017 | -1.02 Mn |
| Jun 30, 2017 | -1.25 Mn |
| Mar 31, 2017 | -1.08 Mn |
| Dec 31, 2016 | -8.99 Mn |
| Sep 30, 2016 | -1.40 Mn |
| Jun 30, 2016 | -11.14 Mn |
| Mar 31, 2016 | -1.61 Mn |
| Dec 31, 2015 | -2.10 Mn |
| Sep 30, 2015 | -2.17 Mn |
| Jun 30, 2015 | -870,000.00 |
API Access
Ligand Pharmaceuticals Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();